期刊文献+

药品不良反应的手性因素 被引量:3

The Chiral Factor of Aadverse Drug Reaction
暂未订购
导出
摘要 综述了国内外有关手性药物的研究进展,归纳了手性药物消旋体及单一对映体间药效学及药动学差异可能导致的不良反应风险因素,介绍了手性药物安全性的研究方法。加强对手性药物的研究,对预防控制其不良反应十分必要。 This paper gives an overview about the current status of domestic and foreign research progress of chiral drugs, summarizes the risk factors of adverse reactions induced by the pharmacodynamics and pharmacokinetic dif- ferences between racemates and enantiomers, describes the research methods of chiral drug safety. To prevent and control the adverse reactions of chiral drugs, it is essential to strengthen the research.
出处 《中国药物警戒》 2013年第10期616-619,共4页 Chinese Journal of Pharmacovigilance
关键词 不良反应 手性药品 药理活性 药动学 adverse reactions chiral drugs pharmacological activity pharmacokinetics
  • 相关文献

参考文献25

  • 1Rentsch K M. The importance of stereoselective determination of drugs in the clinical laboratory[J].J Biochem Biophys Methods2002, 54(1): 1-9.
  • 2Castoldi D, Oggioni A, Renoldi M I, et al. Assay of moguisteine metabolites in human plasma and urine: conventional and chiral high-performance liquid chromatographic methods[J].J Chromatogr B Biomed Appl,1994,655(2): 243-252.
  • 3Oti-Amoako K, Vozeh S, Ha HR, et al. The relative potency of major metabolites and enantiomers ofpropafenone in an experimental reperfusion arrhythmia model [J].J Cardiovasc Pharmacol,1990,15 (1):75-81.
  • 4Gurjar M K. The future lies in chiral purity: a perspective[J]. J Indian Med Assoc,2007,105(4): 177-178.
  • 5Ding Y S, Fowler J S, Volkow N D ,et al. Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and L-threo-methylphenidate in the human and baboon brain[J].Psychopharmacology(Berl), 1997,131(1): 71-78. salivary excretion and red blood cell distribution of the enantiomers[J]. Xenobiotica,1995,25(10): 1127-.
  • 6Smith S W. Chiral toxicology: it's the same thing, only different[J]. Toxicol Sci,2009,110( 1 ): 4-30.
  • 7Svensson S, Mansfield P R. Escitalopram: superior to citalopram or a chiral chimera[J]. Psychother Psychosom,2004,73(1):10-16.
  • 8Zhang J, Zhou F, Niu F ,et al. Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics[J]. PLoS One, 2012,7(4): e35768.
  • 9Reddy I K, Kommuru T R, Zaghloul A A, et al. Chirality and its implications in transdermal drug development[J]. Crit Rev Ther Drug Carrier Syst,2000,17(4):285-325.
  • 10Cizmarikova R, Valentova J, Hutta J A. [Adrenergic beta-receptor blockers-a group of chiral drugs: enantioseparation in the group of beta-blockers][J]. Ceska Slov Farm,2004,53(1): 9-17.

同被引文献21

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部